Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Cullinan Therapeutics Inc (NASDAQ: CGEM) closed at $13.45 down -2.96% from its previous closing price of $13.86. In other words, the price has decreased by -$2.96 from its previous closing price. On the day, 0.51 million shares were traded. CGEM stock price reached its highest trading level at $14.145 during the session, while it also had its lowest trading level at $13.14.
Ratios:
For a deeper understanding of Cullinan Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 24.46 and its Current Ratio is at 24.46. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on October 24, 2024, initiated with a Buy rating and assigned the stock a target price of $30.
On May 01, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $40.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 05 ’24 when Michaelson Jennifer sold 8,000 shares for $15.64 per share. The transaction valued at 125,120 led to the insider holds 107,942 shares of the business.
Michaelson Jennifer sold 8,000 shares of CGEM for $144,720 on Sep 05 ’24. The Chief Scientific Officer now owns 115,942 shares after completing the transaction at $18.09 per share. On Sep 05 ’24, another insider, JENNIFER MICHAELSON & MARC D M, who serves as the Officer of the company, bought 16,000 shares for $18.68 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGEM now has a Market Capitalization of 783161216 and an Enterprise Value of 231402432.
Stock Price History:
Over the past 52 weeks, CGEM has reached a high of $30.19, while it has fallen to a 52-week low of $7.64. The 50-Day Moving Average of the stock is -18.21%, while the 200-Day Moving Average is calculated to be -27.29%.
Shares Statistics:
For the past three months, CGEM has traded an average of 526.94K shares per day and 632800 over the past ten days. A total of 42.90M shares are outstanding, with a floating share count of 37.06M. Insiders hold about 36.36% of the company’s shares, while institutions hold 77.28% stake in the company. Shares short for CGEM as of 1730332800 were 9021016 with a Short Ratio of 17.12, compared to 1727654400 on 9208641. Therefore, it implies a Short% of Shares Outstanding of 9021016 and a Short% of Float of 17.959999.
